Company Overview of Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutics for treating patients with type 1 and type 2 diabetes. It focuses on the development of VPI-2690B, a subcutaneously administered monoclonal antibody that is stimulated by hyperglycemia for the treatment of diabetic nephropathy. The company was founded in 2005 and is based in Research Triangle Park, North Carolina.
79 TW Alexander Drive
Research Triangle Park, NC 27709
Founded in 2005
Key Executives for Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Hanson Technologies, Inc.||United States|
|ProSci Incorporated||United States|
|Xeragon, Inc.||United States|
|Eve Biomedical, Inc.||United States|
|Sirtex Medical Inc.||United States|
Recent Private Companies Transactions
December 23, 2015
To contact Vascular Pharmaceuticals, Inc., please visit www.vascularpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.